The effect of combined delivery of recombinant human bone morphogenetic protein‐2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium‐phosphate‐coated implants on osseointegration
Mustafa Ramazanoğlu(Istanbul Technical University), Karl Andreas Schlegel(Friedrich-Alexander-Universität Erlangen-Nürnberg), Rainer Lutz(Universitätsklinikum Erlangen), Cornelius von Wilmowsky(Friedrich-Alexander-Universität Erlangen-Nürnberg), Celaletdin Ergun(Istanbul Technical University), Emeka Nkenke(Medical University of Vienna)
Cited by 63
Related Papers
Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements
|Nucleic Acids Research|1997|1.8k
Periodontal Disease as a Risk Factor for Ischemic Stroke
|Stroke|2004|351
<i>In vivo</i> evaluation of anodic TiO<sub>2</sub> nanotubes: An experimental study in the pig
|Journal of Biomedical Materials Research Part B Applied Biomaterials|2008|226
Histological results after maxillary sinus augmentation with Straumann® BoneCeramic, Bio‐Oss®, Puros®, and autologous bone. A randomized controlled clinical trial
|Clinical Oral Implants Research|2012|199
<i>In vivo</i> performance of selective electron beam‐melted Ti‐6Al‐4V structures
|Journal of Biomedical Materials Research Part A|2009|179